In this episode, we are joined by Dr. Tom Beer, Chief Medical Officer and Vice President, Multi-Cancer Early Detection at Exact Sciences, to discuss multi-cancer early detection (MCED) testing and how it is framing the future of cancer screening. Hear Dr. Beer's insights on if the United States has made enough progress in cancer detection and prevention, and the advances in science and technology that are making progress possible. Tune in to hear what we are learning from the early data in MCED testing, how MCED testing can close the gap in disparities in health equity, and Dr. Beer's thoughts on the implementation of effective MCED testing in the future for health systems. This episode is sponsored by Exact Sciences.
Summary
Exploring the Future of Cancer Screening with Multi-Cancer Early Detection (MCED) Testing
Introduction
Join Dr. Tom Beer, Chief Medical Officer and Vice President, Multi-Cancer Early Detection at Exact Sciences, as he discusses the future of cancer screening with MCED testing. In this episode, Dr. Beer shares his insights on the progress made by the United States in cancer detection and prevention, and the advances in science and technology that are making progress possible.
What is MCED Testing?
Dr. Beer is working on developing a blood-based multi-cancer early detection test that can detect multiple different cancers from a single blood test. This technology has the potential to reduce morbidity and mortality from cancer around the world, while also helping to close the gap in disparities in health equity.
Advancements in Technology
Technological advances have often led to increased disparities, but the MCED tests in development are simple blood tests and have the potential to reduce disparities. As a result, health systems may see a shift towards earlier stages of cancer diagnosis and more effective treatments. Exact Sciences has reported the results of an updated four biomarker class test and plans to launch a pivotal large scale interventional trial soon after that.
The Future of MCED Testing
The early data from MCED testing is showing promising results, and Dr. Beer believes that effective implementation of these tests in the future could transform the way we think about cancer screening. Tune in to learn more about what we are learning from MCED testing and Dr. Beer's thoughts on the implementation of effective MCED testing in the future for health systems.
Sponsored by Exact Sciences, this episode offers valuable insights into the future of cancer screening and the exciting possibilities of MCED testing.
Note: This is an AI generated transcript, not edited by a staff writer and is solely intended for educational purposes. If you have any questions/concerns, reach out to podcasts@beckershealthcare.com
This episode aired on 12/08/2022 and can be listened here.
Subscribe to Beckers Healthcare Podcast here.